Cargando…

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders

Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lensberg, Benedikte R, Drummond, Michael F, Danchenko, Natalya, Despiégel, Nicolas, François, Clément
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836685/ https://www.ncbi.nlm.nih.gov/pubmed/24273412 http://dx.doi.org/10.2147/CEOR.S44866

Ejemplares similares

Can discrete event simulation be of use in modelling major depression?
por: Le Lay, Agathe, et al.
Publicado: (2006)

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder
por: François, C, et al.
Publicado: (2008)

Age-Related Increase in the Number of Oligodendrocytes Is Dysregulated in Schizophrenia and Mood Disorders
por: Vostrikov, Victor, et al.
Publicado: (2011)

The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
por: Wimo, Anders, et al.
Publicado: (2016)

Erratum to: The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care
por: Wimo, Anders, et al.
Publicado: (2017)

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder
por: Lam, Raymond W, et al.
Publicado: (2018)

Mood disorders in the elderly: prevalence, functional impact, and management challenges
por: Valiengo, Leandro da Costa Lane, et al.
Publicado: (2016)

Disorders of mood

Creating an index to measure health state of depressed patients in automated healthcare databases: the methodology
por: François, Clément, et al.
Publicado: (2017)

Do food and nutrition have therapeutic value for disorders of mood and conation?
por: Prakash, Jyoti, et al.
Publicado: (2022)

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France
por: Pialoux, Gilles, et al.
Publicado: (2015)

Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis
por: Guyot, Patricia, et al.
Publicado: (2019)

A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity
por: Bezzina, Clive, et al.
Publicado: (2023)

Mood and Activity Measured Using Smartphones in Unipolar Depressive Disorder
por: Tønning, Morten Lindbjerg, et al.
Publicado: (2021)

Chronobiology and mood disorders
por: Wirz-Justice, Anna
Publicado: (2003)

Neuroplasticity in mood disorders
por: Drevets, Wayne C.
Publicado: (2004)

Headache and mood disorders
por: De Filippis, S., et al.
Publicado: (2005)

Psychotherapy of Mood Disorders
por: Picardi, Angelo, et al.
Publicado: (2014)

Cognition in mood disorders
por: Douglas, Katie M., et al.
Publicado: (2020)

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada
por: Despiégel, Nicolas, et al.
Publicado: (2015)

NF-κB Mediated Regulation of Adult Hippocampal Neurogenesis: Relevance to Mood Disorders and Antidepressant Activity
por: Bortolotto, Valeria, et al.
Publicado: (2014)

The effect of vortioxetine on overall patient functioning in patients with major depressive disorder
por: Florea, Ioana, et al.
Publicado: (2017)

Reporting guidelines on remotely collected electronic mood data in mood disorder (eMOOD)—recommendations
por: Faurholt-Jepsen, Maria, et al.
Publicado: (2019)

Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis
por: Iragorri, Nicolas, et al.
Publicado: (2018)

Comprehensive Comparison of Clinically Relevant Grain Proteins in Modern and Traditional Bread Wheat Cultivars
por: Lakhneko, Olha, et al.
Publicado: (2020)

Economic modeling in HIV for maraviroc in France in treatment experienced patients. Results from the ARAMIS 2011 model
por: Despiegel, Nicolas, et al.
Publicado: (2012)

Neurocognitive dysfunction in mood disorders
por: Moore, Brian P., et al.
Publicado: (2003)

Light treatment of mood disorders
por: Parry, Barbara L., et al.
Publicado: (2003)

The Wnt Pathway in Mood Disorders
por: Sani, Gabriele, et al.
Publicado: (2012)

Biological rhythms and mood disorders
por: Salvatore, Paola, et al.
Publicado: (2012)

Mood disorders in cancer patients
por: Husson, O.
Publicado: (2013)

Mood dynamics in bipolar disorder
por: Moore, Paul J, et al.
Publicado: (2014)

Protein biomarkers of mood disorders
por: Rodríguez Cerdeira, Carmen, et al.
Publicado: (2017)

Neural Plasticity in Mood Disorders
por: Hall, F. Scott, et al.
Publicado: (2018)

Editorial: Cognition in Mood Disorders
por: Oyesanya, Mayowa, et al.
Publicado: (2020)

Editorial: Sleep and Mood Disorders
por: Verkhratsky, Alexei, et al.
Publicado: (2020)

Hormonal contraception and mood disorders
por: Mu, Eveline, et al.
Publicado: (2022)

Quality of life and mood disorders
por: Smaoui, N., et al.
Publicado: (2021)

Disruptive mood dysregulation disorder
por: Higueras, P. Hervias
Publicado: (2021)

Suicide in Adolescents with Mood Disorders
por: Shah, K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f6vj0htru37hee5nn492557tn0